Clinical Trials Logo

Clinical Trial Summary

Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity. Ninety-five participants (23<BMI<30 kg/m2) were randomly allocated to three groups: a control group, a 1 g/day NnEx group, and a 2 g/day NnEx group. The effects of the consumption of 2 g/day or 1 g/day NnEx for 12 weeks on indices of adiposity and fasting blood metabolic parameters were compared with those of no consumption of NnEx.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04651023
Study type Interventional
Source Shanghai Meiji Health Science and Technology Co., Ltd.
Contact
Status Completed
Phase N/A
Start date January 10, 2009
Completion date June 20, 2009